Interview with Emmanuel Walckenaer - CEO of Yseop
Close
YSEOP
Yseop is one of the world leaders in Generative Artificial Intelligence (Generative AI) for regulated industries, particularly pharmaceuticals based in France and the United States.
Yseop's SaaS solution makes it possible to transform complex data into natural language (NLG), by automating business rules and respecting the reliability and traceability requirements of demanding processes such as the documentary chain for placing new drugs on the market, clinical studies, financial reports…
In 2023, Yseop has generated more than 10 reports and eliminated tens of thousands of hours of writing and editing. These savings represent potential acceleration for the introduction of new drugs to the market and reinforce Yseop's commitment to bringing life-saving drugs to patients more quickly.
- 16/04/2024
Generative AI for Pharma: 5 Steps for Implementation & Investment
Discover the transformative potential of Generative AI in pharmaceuticals. Dive into five essential steps for implementation and investment, from leveraging competitive advantages to ensuring compliance with industry standards. Unveil the future of Pharma innovation with Generative AI.
The post Generative AI for Pharma: 5 Steps for Implementation & Investment Appeared first on yseop.
- 04/04/2024
Yseop Back-to-Back Finalists at Citeline Awards for Best Use of Artificial Intelligence in Clinical Trials
Finalists at the 2024 Citeline Awards for the Best Use of Artificial Intelligence in Clinical Trials
The post Yseop Back-to-Back Finalists at Citeline Awards for Best Use of Artificial Intelligence in Clinical Trials Appeared first on yseop.
- 21/03/2024
AI 101: Guide for medical writers
Emmanuel Walckenaer, CEO of Yseop, dives into how medical writers and pharma companies can get started in AI 101: Guide for Medical Writers.
The post AI 101: Guide for medical writers Appeared first on yseop.
- 21/03/2024
Yseop Shortlisted for Business Intelligence Group's Artificial Intelligence Excellence Awards
Yseop has been honored as a finalist in the 2024 Business Intelligence Group's Artificial Intelligence Excellence Awards.
The post Yseop Shortlisted for Business Intelligence Group's Artificial Intelligence Excellence Awards Appeared first on yseop.
- 08/03/2024
The Promise & Challenge Of Deploying AI In Clinical Trials
Tim Martin, Executive VP of Product & Development at Yseop was recently featured in Forbes discussing AI regulation and the EU AI Act.
The post The Promise & Challenge Of Deploying AI In Clinical Trials Appeared first on yseop.
- 06/03/2024
AI Uncovered with Fred Schonenberg (The Vital Role of GenAI in Enterprises)
Listen to the eighth episode of AI Uncovered with Fred Schonenberg
The post AI Uncovered with Fred Schonenberg (The Vital Role of GenAI in Enterprises) Appeared first on yseop.
- 09/02/2024
Yseop Copilot vs. Alternative GenAI Technologies
See how Yseop Copilot is different from other Generative AI technologies across BioPharma and regulated industries.
The post Yseop Copilot vs. Alternative GenAI Technologies Appeared first on yseop.
- 24/01/2024
The Promise And Challenge Of Deploying AI In Clinical Trials
Reinforcing Yseop's unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.
The post The Promise And Challenge Of Deploying AI In Clinical Trials Appeared first on yseop.
- 03/01/2024
A Recap of Pharma AI Trends in 2023
Generative AI technologies enable the pharmaceutical industry to provide enhanced and quality content automation.
The post A Recap of Pharma AI Trends in 2023 Appeared first on yseop.
- 21/12/2023
Yseop in 2023: A Year of Growth, Gratitude, & GenAI
Explore the remarkable milestones and moments that shaped Yseop's journey in life sciences in 2023.
The post Yseop in 2023: A Year of Growth, Gratitude, & GenAI Appeared first on yseop.
- 18/12/2023
Yseop announces the closing of a major strategic investment round marked by the entry of Novartis as a new investor
Yseop announces the closing of a major strategic investment round, marked by the entry of Novartis as a new investor, and celebrates its ...
- 17/10/2023
Yseop won the Citeline 2023 prize for “Best use of artificial intelligence in clinical trials”
Yseop won the 2023 Citeline Award for “Best Use of Artificial Intelligence in Clinical Trials” for the industry ...
- 14/06/2023
Yseop was nominated for the World Technology Leader Award 2023
Yseop has been nominated for the 2023 World Technology Leader Award. The World Technology Leader Award recognizes technological excellence and innovation in all ...
- 20/01/2023
[NEWS] Yseop, Chat GPT: language processing models
“In the gigantic ocean of knowledge that is the Web, Google Search helped to navigate. ChatGPT builds islands where ...
- 16/01/2023
[VIDEO]: Words of Entrepreneurs, Emmanuel Walckenaer, CEO of Yseop
"We partnered with NextStage AM 5 years ago and it's the best decision we ...
- 29/11/2022
L'Oréal deploys the disruptive AI platform Yseop to boost its financial performance
Yseop, capitalizing on its artificial intelligence platform in the generation of content enriched in natural language (NLG), supports L'Oréal in ...
- 22/04/2021
Yseop recognized as “Best AI Product: Enterprise” at the 2021 Technical Analyst Awards
Find this news on: https://www.yseop.com/Best_Enterprise_AI_Product_award- 13/10/2020
Yseop announces the expansion of its strategic committee to further accelerate its growth
Find this news on: https://www.yseop.com/Yseop-Announces-The-Expansion-Of-Its-Strategic-Committee-To-Further-Accelerate-Growth- 07/01/2020
Yseop and Litera Partner to Speed Up Regulatory Submission Processes for Life Sciences Companies
Find this news on: https://www.yseop.com/news/yseop-and-litera-partner-to-fast-track-regulation-submission-processes-for-life-sciences-companies-
Digital
-
Industrial Internet
Alain Kaeser
Strategy Director and Co-Founder
Biography
Alain Kaeser, has more than 25 years of experience in the fields of knowledge engineering, Artificial Intelligence and language sciences. Graduated in mathematics from the Ecole Normale Supérieure de Cachan and holder of a DEA in computer science from the University of Paris VI, he created in 1985, a decision support software combining management of business rules and automatic generation. natural language. Alain then continued his research in Artificial Intelligence and co-founded Yseop in 2007.
Emmanuel Walckenaer
Director General
Biography
Before joining Yseop in September 2017, Emmanuel was Senior VP and General Manager of two successive departments including the Cloud & Connectivity Business BU of Sierra Wireless (designer and multinational manufacturer of wireless communications equipment) where he developed the activity of services (recurring turnover increased from $ 1m to $ 30m in 3 years) and integrated 3 acquisitions (Sweden, France and USA) in 18 months. Before his 9 years at Sierra Wireless, he worked for ten years at Gemalto - Gemplus (world leader in digital security - CA $ 1,7 billion) where he was notably Senior VP of the Software Telecom BU and introduced disruptive innovations in each product line. He graduated from Centrale Paris with a specialty in “Applied Mathematics and Artificial Intelligence”.
Grégoire Sentilhes
President
Michael Strauss-Kahn
Partner